{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:32:41Z","timestamp":1790908361860,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.bbr.2010.06.014","type":"journal-article","created":{"date-parts":[[2010,6,21]],"date-time":"2010-06-21T04:21:14Z","timestamp":1277094074000},"page":"417-422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio)"],"prefix":"10.1016","volume":"214","author":[{"given":"Kelly Juliana","family":"Seibt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata da Luz","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Francine","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati\u00facia Marques","family":"Capiotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maur\u00edcio Reis","family":"Bogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Ghisleni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Denise","family":"Bonan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2010.06.014_bib1","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0006-3223(01)01195-7","article-title":"Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex","volume":"50","author":"Adams","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2010.06.014_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/schbul\/sbm167","article-title":"Cochrane schizophrenia group","volume":"34","author":"Adams","year":"2008","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bbr.2010.06.014_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(99)01224-X","article-title":"Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release","volume":"825","author":"Aghajanian","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2010.06.014_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0166-4328(99)00101-1","article-title":"The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat","volume":"106","author":"Akwa","year":"1999","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2010.06.014_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10897-005-1622-4","article-title":"Schizophrenia: an update and review","volume":"14","author":"Austin","year":"2005","journal-title":"J Genet Couns"},{"key":"10.1016\/j.bbr.2010.06.014_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-003-1558-z","article-title":"Anxiolytic-like effects of NMDA\/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats","volume":"170","author":"Bertoglio","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2010.06.014_bib7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2147\/NDT.S2056","article-title":"Zebrafish: an in vivo model for the study of neurological diseases","volume":"4","author":"Best","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.bbr.2010.06.014_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130000472","article-title":"The neurosteroid pregnanolone prevents the anxiogenic-like effect of inescapable shock in the rat","volume":"151","author":"Bitran","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2010.06.014_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(97)00096-4","article-title":"The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors","volume":"325","author":"Brot","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2010.06.014_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jphysparis.2003.10.009","article-title":"Steps during the development of the zebrafish locomotor network","volume":"97","author":"Brustein","year":"2003","journal-title":"J Physiol (Paris)"},{"key":"10.1016\/j.bbr.2010.06.014_bib11","first-page":"1","article-title":"The effect of a full agonist\/antagonist of the D1 receptor on locomotor activity, sensorimotor gating and cognitive function in dizocilpine-treated rats","author":"Bubenikova-Valesova","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2010.06.014_bib12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","article-title":"Interactions between glutamatergic and monoaminergic systems within the basal ganglia\u2014implications for schizophrenia and Parkinson's disease","volume":"13","author":"Carlsson","year":"1990","journal-title":"Trends Neurosci"},{"issue":"1","key":"10.1016\/j.bbr.2010.06.014_bib13","first-page":"324","article-title":"Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists","volume":"30","author":"Chartoff","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2010.06.014_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ddr.430020204","article-title":"Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo [d]cyclohepten-5,10-immine(MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties","volume":"2","author":"Clineschmidt","year":"1982","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.bbr.2010.06.014_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF02246146","article-title":"Antipsychotic agents antagonize non-competitive N-methyl-d-aspartate antagonist-induced behaviors","volume":"120","author":"Corbett","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2010.06.014_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00002826-199710000-00001","article-title":"Behavioral approaches to the functional assessment of NMDA-mediated neural transmission in intact mice","volume":"20","author":"Deutsch","year":"1997","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.bbr.2010.06.014_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(89)90811-X","article-title":"Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze","volume":"169","author":"Dunn","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2010.06.014_bib18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.conb.2004.10.008","article-title":"Genes and photons: new avenues into the neuronal basis of behavior","volume":"14","author":"Fetcho","year":"2004","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.bbr.2010.06.014_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-1781(99)00027-X","article-title":"Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls","volume":"86","author":"Flyckt","year":"1999","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2010.06.014_bib20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF01294789","article-title":"Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats","volume":"96","author":"Gattaz","year":"1994","journal-title":"J Neural Transm Gen Sect"},{"key":"10.1016\/j.bbr.2010.06.014_bib21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbr.2009.03.003","article-title":"Zebrafish (Danio rerio) responds to the animated image of a predator: towards the development of an automated aversive task","volume":"201","author":"Gerlai","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2010.06.014_bib22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0091-3057(00)00422-6","article-title":"Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects","volume":"67","author":"Gerlai","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2010.06.014_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2010.06.014_bib24","series-title":"Neuropsychopharmacology: the fifth generation of progress","first-page":"689","article-title":"Animal models relevant to schizophrenia disorders","author":"Geyer","year":"2002"},{"key":"10.1016\/j.bbr.2010.06.014_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ntt.2006.01.013","article-title":"Antipsychotics produce locomotor impairment in larval zebrafish","volume":"28","author":"Giacomini","year":"2006","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.bbr.2010.06.014_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1601-183X.2003.00053.x","article-title":"Linking genes to brain, behavior and neurological diseases: what can we learn from zebrafish?","volume":"3","author":"Guo","year":"2004","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.bbr.2010.06.014_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(98)00308-2","article-title":"Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens","volume":"351","author":"Ichikawa","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2010.06.014_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ntt.2009.04.066","article-title":"Acute neuroactive drug exposures alter locomotor activity in larval zebrafish","volume":"32","author":"Irons","year":"2010","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.bbr.2010.06.014_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2010.06.014_bib30","series-title":"Developing new drugs for schizophrenia: from animals to the clinic. Animal and translational models for CNS drug discovery volume 1: psychiatric disorders","first-page":"199","author":"Jones","year":"2008"},{"key":"10.1016\/j.bbr.2010.06.014_bib31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJM199601043340109","article-title":"Schizophrenia","volume":"334","author":"Kane","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbr.2010.06.014_bib32","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0028-3908(97)00130-5","article-title":"Anxiolytic activity of glycine-B antagonists and partial agonists\u2014no relation to intrinsic activity in the patch clamp","volume":"36","author":"Karcz-Kubicha","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2010.06.014_bib33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sj.clpt.6100223","article-title":"Zebrafish: an emerging model system for human disease and drug discovery","volume":"82","author":"Kari","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bbr.2010.06.014_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1139\/jpn.0336","article-title":"Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects","volume":"28","author":"Kiang","year":"2003","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.bbr.2010.06.014_bib35","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0006-3223(01)01286-0","article-title":"The changing roles and targets for animal models of schizophrenia","volume":"50","author":"Kilts","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2010.06.014_bib36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/026988119901300405","article-title":"Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies","volume":"13","author":"Laruelle","year":"1999","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.bbr.2010.06.014_bib37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.physbeh.2006.08.026","article-title":"Anxiolytic effects of nicotine in zebrafish","volume":"90","author":"Levin","year":"2007","journal-title":"Physiol Behav"},{"key":"10.1016\/j.bbr.2010.06.014_bib38","first-page":"5","article-title":"Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity","volume":"55","author":"Leysen","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbr.2010.06.014_bib39","first-page":"30","article-title":"Hyperglycemia associated with the use of atypical antipsychotics","volume":"62","author":"Lindenmayer","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbr.2010.06.014_bib40","first-page":"83","article-title":"Steroid regulation of the GABAA receptor: ligand binding, chloride transport and behaviour","volume":"153","author":"Majewska","year":"1990","journal-title":"Ciba Found Symp"},{"key":"10.1016\/j.bbr.2010.06.014_bib41","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/oxfordjournals.schbul.a007084","article-title":"Earlier age of first diagnosis in schizophrenia is related to impaired motor control","volume":"30","author":"Manschreck","year":"2004","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bbr.2010.06.014_bib42","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.pnpbp.2007.03.017","article-title":"Delayed alternation performance following subchronic phencyclidine administration in rats depends on task parameters","volume":"31","author":"Marquis","year":"2007","journal-title":"Prog Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2010.06.014_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1300015","article-title":"Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents","volume":"28","author":"Marx","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2010.06.014_bib44","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.pbb.2006.07.026","article-title":"Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: candidate mechanism for superior efficacy?","volume":"84","author":"Marx","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2010.06.014_bib45","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1365-2125.1990.tb05444.x","article-title":"A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers","volume":"30","author":"McClelland","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bbr.2010.06.014_bib46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jpsychires.2004.08.002","article-title":"Extrapyramidal symptoms in unmedicated schizophrenia","volume":"39","author":"McCreadie","year":"2005","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.bbr.2010.06.014_bib47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/zeb.2008.0564","article-title":"Modular laboratory exercises to analyze the development of zebrafish motor behavior","volume":"6","author":"McKeown","year":"2009","journal-title":"Zebrafish"},{"key":"10.1016\/j.bbr.2010.06.014_bib48","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2010.06.014_bib49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/00223980209604159","article-title":"Phencyclidine (PCP): a dangerous drug, but useful in schizophrenia research","volume":"136","author":"Murray","year":"2002","journal-title":"J Psychol"},{"key":"10.1016\/j.bbr.2010.06.014_bib50","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(98)00067-0","article-title":"Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis","volume":"20","author":"Newcomer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2010.06.014_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00982-0","article-title":"Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine","volume":"368","author":"Ninan","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2010.06.014_bib52","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","article-title":"NMDA receptor hypofunction model of schizophrenia","volume":"33","author":"Olney","year":"1999","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.bbr.2010.06.014_bib53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s002130051055","article-title":"Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice","volume":"145","author":"O\u2019Neill","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2010.06.014_bib54","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00213-003-1669-6","article-title":"Modulation of nerve growth factor and choline acetyltransferase expression in rat hippocampus after chronic exposure to haloperidol, risperidone, and olanzapine","volume":"172","author":"Parikh","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2010.06.014_bib55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/154065802761001293","article-title":"Zebrafish: a preclinical model for drug screening","volume":"1","author":"Parng","year":"2002","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.bbr.2010.06.014_bib56","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/35103567","article-title":"The art and design of genetic screens: zebrafish","volume":"2","author":"Patton","year":"2001","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.bbr.2010.06.014_bib57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0920-9964(00)00035-9","article-title":"Motor features in psychotic disorders. II. Development of diagnostic criteria for catatonia","volume":"47","author":"Peralta","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bbr.2010.06.014_bib58","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1124\/jpet.110.166710","article-title":"Behavioral indices in antipsychotic drug discovery","volume":"333","author":"Porsolt","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2010.06.014_bib59","doi-asserted-by":"crossref","first-page":"15651","DOI":"10.1073\/pnas.0602639103","article-title":"Fronto-cerebellar systems are associated with infant motor and adult executive functions in healthy adults but not in schizophrenia","volume":"103","author":"Ridler","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2010.06.014_bib60","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biopsych.2005.08.029","article-title":"A pharmacological model for psychosis based on N-methyl-d-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities","volume":"59","author":"Rujescu","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2010.06.014_bib61","first-page":"10","article-title":"Typical and atypical antipsychotics alter acetylcholinesterase activity and ache expression in zebrafish (Danio rerio) brain","volume":"150","author":"Seibt","year":"2009","journal-title":"Comp Biochem Physiol C"},{"key":"10.1016\/j.bbr.2010.06.014_bib62","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbr.2009.02.007","article-title":"Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801","volume":"204","author":"Seillier","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2010.06.014_bib63","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.tiv.2005.12.002","article-title":"In vitro effect of zinc and cadmium on acetylcholinesterase and ectonucleotidase activities in zebrafish (Danio rerio) brain","volume":"20","author":"Senger","year":"2006","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.bbr.2010.06.014_bib64","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pbb.2009.12.008","article-title":"Post-weaning social isolation increases activity in a novel environment but decreases defensive burying and subchronic MK-801 enhances the activity but not the burying effect in rats","volume":"95","author":"Simpson","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2010.06.014_bib65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1176\/ajp.130.1.61","article-title":"Amphetamine psychosis: a \u2018model\u2019 schizophrenia mediated by catecholamines","volume":"130","author":"Snyder","year":"1973","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2010.06.014_bib66","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejphar.2007.02.031","article-title":"Risperidone attenuates MK-801-induced hyperlocomotion in mice via the blockade of serotonin 5-HT2A\/2C receptors","volume":"564","author":"Su","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2010.06.014_bib67","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1741-8372(04)02428-4","article-title":"Zebrafish as a model system for drug target screening and validation","volume":"3","author":"Sumanasa","year":"2004","journal-title":"Drug Discov Today Targets"},{"key":"10.1016\/j.bbr.2010.06.014_bib68","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ntt.2004.06.009","article-title":"Effects of dizocilpine (MK-801) on circling behavior, swimming activity, and place preference in zebrafish (Danio rerio)","volume":"26","author":"Swain","year":"2004","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.bbr.2010.06.014_bib69","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1034\/j.1600-0447.2000.101006416.x","article-title":"Atypical antipsychotics and weight gain\u2014a systemic review","volume":"101","author":"Taylor","year":"2000","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.bbr.2010.06.014_bib70","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0920-9964(99)00154-1","article-title":"Comparative evaluation of conventional and new antipsychotic drugs with reference to their subjective tolerability, side effect profile and impact on quality of life","volume":"43","author":"Voruganti","year":"2000","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bbr.2010.06.014_bib71","series-title":"The zebrafish book","author":"Westerfield","year":"2007"},{"key":"10.1016\/j.bbr.2010.06.014_bib72","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1017\/S0033291703008225","article-title":"Prospective evaluation of neurological soft signs in first-episode schizophrenia in relation to psychopathology: state versus trait phenomena","volume":"33","author":"Whitty","year":"2003","journal-title":"Psychol Med"},{"key":"10.1016\/j.bbr.2010.06.014_bib73","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0149-7634(03)00035-6","article-title":"Schizophrenia: from phenomenology to neurobiology","volume":"27","author":"Wong","year":"2003","journal-title":"Neurosci Biobehav Rev"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432810004584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432810004584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:59:12Z","timestamp":1759064352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432810004584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0166432810004584"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2010.06.014","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio)","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2010.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}